OUR PRODUCT

CNSA-001 is an oral formulation of synthetic sepiapterin, an endogenous naturally occurring pterin

RATIONAL

CNSA-001 is efficiently converted into tetrahydrobiopterin, a cofactor for critical cell-based enzymes

DEVELOPMENT

CNSA-001 is being developed to correct deficiencies in tetrahydrobiopterin dependent pathways

 

 

Developing Medicines to Improve the Lives of Patients with Debilitating Diseases

 

News